Titolo: Cannabinoids

Home

/

Specialità

/

Psichiatria - Psicologia - Scienze Psicologiche

/

Cannabinoids

Editore

Minerva Medica

Anno

2025

Pagine

214

ISBN

9788855322676

I prezzi indicati possono subire variazioni poiché soggetti all'oscillazione dei cambi delle valute e/o agli aggiornamenti effettuati dagli Editori.

Dettagli Indice Recensioni (0)

For a very long time, cannabis has been one of the most widely used illicit drugs worldwide. However, particularly over the last few years, its legal status has been changing across many geographical jurisdictions. With growing public interest in the medicinal use of cannabis-derived molecules and changing public perception about cannabis, understanding the pharmacological principles underlying the effects of cannabinoids, their therapeutic potential as well as adverse effects has become more important than ever. This has been accompanied by an explosion in scientific research focused on cannabinoids, particularly over the past couple of decades and scientific journals dedicated to cannabis and cannabinoid research have joined the ranks of scientific publishing. Hence, there is a particular need to summarize this growing body of evidence for the wider scientific community. This book aims to address this need by providing a critical overview on a range of topics relevant to understanding the effect of cannabinoids on human health. It is made up of three parts, further divided into various sections. In compiling this book the authors have endeavored to provide a balanced overview of the state-of-the-art evidence regarding cannabinoids with particular relevance to neuropsychiatric conditions. Written by a diverse group of scientists and clinicians, the various chapters and sections provide a comprehensive examination of the adverse effects and therapeutic potential of cannabinoids underpinned by relevant cannabinoid pharmacology. This book will serve as a valuable resource for researchers, clinicians and students.

Endocannabinoid system and cannabinoids : principles of pharmacology

Anna Lauritano, Fabiana Piscitelli, Katarzyna Starowicz, Natalia Malek

Cannabinoids exposure in vulnerable period of brain development. Preclinical evidence

Roberto Frau, Miriam Melis

Cannabinoids and emotionality. Lessons from preclinical research

Brandon Richardson, Courtney Clarke, Francis R. Bambico

Animal models of cannabinoid reward

Sara R. Westbrook, Max W. Melville, Lydia N. Baxter-Potter, Ryan J. McLaughlin

Endocannabinoid-like compounds and their influence in chronic diseases and their comorbidities Focus on N-palmitoylethanolamide

Serena Boccella, Andrea M. Morace, Federica Ricciardi, Antimo Fusco, Michela Perrone, Rosmara Infantino, Ida Marabese, Enza Palazzo, Livio Luongo, Francesca Guida, Francesca Gargano, Sabatino Maione

Lessons learned from studies of the acute effects of cannabinoids on human health

Daniele Cavaleri, Giuseppe Carrà, Francesco Bartoli

Epidemiological evidence of the risk of severe mental disorders in the context of cannabis use

Branko Ristic, Sarah Tosato

Cannabinoids and psychopathology. Evidence from the real world

Franca Ceci, Nicola Ciraselli, Claudia Certelli, Giovanni Martinotti

Synthetic cannabinoids , the largest and most diverse group of novel psychoactive substances

Duccio P. Papanti, Laura Orsolini, John M. Corkery, Stefania Chiappini, Amira Guirguis, Alessandro Vento, Fabrizio Schifano

Is there a role for cannabinoids in cognitive function?

Laura Ferraro

Neurobiological underpinnings of the effects of cannabinoids

Enrico Bonomo, Daniele Pagliaro, Marco Colizzi